Tenofovir disoproxil fumarate associated Fanconi syndrome in an HIV-uninfected man receiving HIV pre-exposure prophylaxis

被引:0
|
作者
Dube, M. P. [1 ]
Funk, C. A. [1 ]
Corado, K. [2 ]
Morris, S. [3 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA
[3] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A57
引用
收藏
页码:A57 / A57
页数:1
相关论文
共 50 条
  • [41] Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017
    Sullivan, Patrick S.
    Giler, Robertino Mera
    Mouhanna, Farah
    Pembleton, Elizabeth S.
    Jones, Jeb
    Castel, Amanda D.
    Yeung, Howa
    Kramer, Michael
    McCallister, Scott
    Siegler, Aaron J.
    ANNALS OF EPIDEMIOLOGY, 2018, 28 (12) : 833 - 840
  • [42] Pill related oesophagitis due to tenofovir disproxil fumarate/emtricitabine (Truvada) HIV pre-exposure prophylaxis
    Bonnichsen, Mark H.
    Tschuchnigg, Mark
    Post, Jeffrey J.
    Bye, William
    INTERNAL MEDICINE JOURNAL, 2022, 52 (06) : 1099 - 1100
  • [43] Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis
    Havens, Peter L.
    Stephensen, Charles B.
    Van Loan, Marta D.
    Schuster, Gertrud U.
    Woodhouse, Leslie R.
    Flynn, Patricia M.
    Gordon, Catherine M.
    Pan, Cynthia G.
    Rutledge, Brandy
    Liu, Nancy
    Wilson, Craig M.
    Hazra, Rohan
    Hosek, Sybil G.
    Anderson, Peter L.
    Seifert, Sharon M.
    Kapogiannis, Bill G.
    Mulligan, Kathleen
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 317 - 325
  • [44] Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial
    Kibengo, Freddie M.
    Ruzagira, Eugene
    Katende, David
    Bwanika, Agnes N.
    Bahemuka, Ubaldo
    Haberer, Jessica E.
    Bangsberg, David R.
    Barin, Burc
    Rooney, James F.
    Mark, David
    Chetty, Paramesh
    Fast, Patricia
    Kamali, Anatoli
    Priddy, Frances H.
    PLOS ONE, 2013, 8 (09):
  • [45] HIV pre-exposure prophylaxis
    Sharma, Malika
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : E588 - E588
  • [46] HIV Pre-Exposure Prophylaxis
    Liegeon, Geoffroy
    Delaugerre, Constance
    Molina, Jean-Michel
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 453 - 474
  • [47] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [48] HIV pre-exposure prophylaxis
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [49] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [50] Electrospun fibers for vaginal administration of tenofovir disoproxil fumarate and emtricitabine in the context of topical pre-exposure prophylaxis
    Nunes, Rute
    Bogas, Sarah
    Faria, Maria Joao
    Goncalves, Hugo
    Lucio, Marlene
    Viseu, Teresa
    Sarmento, Bruno
    das Neves, Jose
    JOURNAL OF CONTROLLED RELEASE, 2021, 334 (334) : 453 - 462